RenBio, Inc. Sustainability Profile
RenBio, Inc., a leading biotechnology firm headquartered in the United States, has been at the forefront of innovative solutions since its inception in 2015. With a strong focus on developing advanced therapeutics and diagnostics, RenBio operates primarily in the biopharmaceutical sector, catering to a diverse range of medical needs. The company is renowned for its proprietary platform that harnesses the power of biologics to create unique treatments for various diseases. RenBio's commitment to research and development has positioned it as a key player in the industry, achieving significant milestones in clinical trials and product launches. With a growing portfolio of core products, RenBio continues to make strides in enhancing patient outcomes and advancing healthcare solutions globally.
DitchCarbon Score
How does RenBio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RenBio, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RenBio, Inc.'s reported carbon emissions
RenBio, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that RenBio, Inc. may still be in the early stages of developing its climate commitments or reporting framework. As of now, there are no emissions inherited from a parent company or cascaded from any corporate family relationships, indicating that RenBio, Inc. operates independently in this regard. The company has not yet established any industry-standard climate initiatives such as Science Based Targets (SBTi) or commitments to renewable energy (RE100). In summary, while RenBio, Inc. has not provided specific emissions data or reduction targets, it is essential for the company to develop a robust climate strategy to align with industry standards and contribute to global climate goals.
How Carbon Intensive is RenBio, Inc.'s Industry?
How Carbon Intensive is RenBio, Inc.'s Location?
RenBio, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RenBio, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
